Clinical

Dataset Information

VNP40101M in Treating Patients With Advanced Solid Tumors or Lymphomas


ABSTRACT: RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. PURPOSE: Phase I trial to study the effectiveness of VNP40101M in treating patients who have advanced solid tumors or lymphomas.

DISEASE(S): Small Intestine Cancer,Angioimmunoblastic T-cell Lymphoma,Lymphoma,Intestinal Neoplasms,Unspecified Adult Solid Tumor, Protocol Specific

PROVIDER: 2006767 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR